Royal Bank of Canada
NURO

Royal Bank of Canada’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Royal Bank of Canada’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-38
Closed -$3K – 7986
2021
Q3 		$3K Buy
+38
New +$3.4K ﹤0.01% 7284
2020
Q3 		– Sell
-500
Closed -$8K – 7029
2020
Q2 		$8K Buy
+500
New +$8.63K ﹤0.01% 5923
2019
Q2 		– Sell
-2
Closed – – 7279
2019
Q1 		$0 Buy
+2
New +$166 ﹤0.01% 7186

Other funds holding NURO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SC
Stephens Consulting Flint, Michigan $309M AUM 14.46% 1-Year Est. Return

Royal Bank of Canada's NURO Position: Q4 2021 in Review

Royal Bank of Canada sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2021, closing a stake of 38 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in NURO in Q1 2019 and held it in 3 quarters. The position peaked at $8K in Q2 2020. 17 funds tracked by Wall St. Rank hold NURO as of Q4 2021.

  • Royal Bank of Canada reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 38 NeuroMetrix, Inc. Common Stock shares in Q4 2021, an estimated $3K.
  • Royal Bank of Canada first reported a position in NeuroMetrix, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • Royal Bank of Canada's NeuroMetrix, Inc. Common Stock position peaked at $8K in Q2 2020.
  • 17 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2021.

Based on Royal Bank of Canada's 13F filing for Q4 2021, filed 14 Feb 2022.